RE:Last shakeout before the epic runPerhaps existing partners would be interested with being involved with the new purposed trauma testing identifier. There are many different areas where head trauma victims could use this test method. It would not be a surprise if other big drug companies announce that they are working on the same test and that is where we see if SONA has unique GNR, compared the nanospheres offered by other companies. If they brought the Covid-19 identifier to fruition most efficiently, and say they have learnt from the process, could the timeline may be different if ramped up by friendly Nations toward SONA? It may be prudent to do multiple testing in multiple nations to gather overwhelming data and not limit themselves in their scope. They are developing relationships around the world that may be very interested in helping in developing this new product. This is another step in this chaos and the share price will find its way, in time. IMO